The potential of aromatase inhibitors in breast cancer prevention.

Keywords

Aromatase, Estrogen, Breast cancer, Internal medicine, Cancer research

References

• Resistance of the ovary to blockade of aromatization with aminoglutethimide.Richard J. Santen, E Samojlik, Samuel A. Wells — 1980
• Aromatase expression in health and disease.Evan R. Simpson, Ying Zhao, Veena R. Agarwal — 1997
• Etiology:Chemical and Physical CarcinogenesisFrederick F. Becker — 1982
• Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue.A.A.J. van Landeghem, J. Poortman, M.J.A. Nabuurs — 1985
• Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.Rajeshwar R. Tekmal, Nandini Ramachandra, Siddeswar Gubba — 1996
• Breast cancer and artificial menopause: a cohort study.Manning Feinleib — 1968
• Menopause and breast cancer risk.Dimitrios Trichopoulos, Brian MacMahon, Philip A. Cole — 1972
• Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.Trevor J. Powles, Rosalind A. Eeles, S. Ashley — 1998
• Gene expression screening for specific genes associated with mouse mammary tumor developmentLixin Zhang, Daniel Medina — 1993
• The overexpression of int-5/Aromatase, a novel MMTV integration locus gene, is responsible for D2 mammary tumor cell proliferation.Rajeshwar R. Tekmal, Vijayender Rao Durgam — 1995
• Is tamoxifen effective in prevention of breast cancer?Kathleen I. Pritchard — 1998
• Epidemiologic evidence for the increased cell proliferation model of carcinogenesis.Susan Preston‐Martin, Malcolm C. Pike, R K Ross — 1993
• A prospective study of endogenous estrogens and breast cancer in postmenopausal women.Paolo Toniolo, Mortimer Levitz, Anne Zeleniuch‐Jacquotte — 1995
• The importance of local synthesis of estrogen within the breast.William R. Miller, John S. O’Neill — 1987
• An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia.Patricia Coen, Howard E. Kulin, Thomas V.N. Ballantine — 1991
• Prognostic value of breast cancer aromataseAllan Lipton, Richard J. Santen, Steven J. Santner — 1992
• Body size in different periods of life and breast cancer risk in post‐menopausal womenCecilia Magnusson, John A. Baron, Ingemar Persson — 1998
• Serum sex hormone levels are related to breast cancer risk in postmenopausal women.Joanne F. Dorgan, Christopher Longcope, Hugh E. Stephenson — 1997
• Stromal spindle cells contain aromatase in human breast tumors.Richard J. Santen, Jan Martel, Martin S. Hoagland — 1994
• Distribution of aromatase P450 transcripts and adipose fibroblasts in the human breast.S E Bulun, Garima Sharda, John L. Rink — 1996

Cited by

• Gemcitabine plus cisplatin in breast cancer.Robert Alan Nagourney — 2001
• The use of simvastatin with aromasin in an ovariectomized rat model: effects on the skeletal system.Sung-Hsiung Chen, Fong‐Fu Chou, Jih‐Yang Ko — 2010
• Power frequency electromagnetic fields, melatonin and the risk of breast cancer.Anthony J. Swerdlow — 2006
• Microfluidic biosensing systems based on enzymes, antibodies and cellsRichard Davidsson — 2004
• Oestrogen receptor downregulation: an opportunity for extending the window of endocrine therapy in advanced breast cancer.Martine Piccart, L M Parker, Kathleen I. Pritchard — 2003
• Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate.Moon Young Heo, Su Jung Sohn, William W. Au — 2001
• Breast cancer chemoprevention: current challenges and a look toward the future.Carol J. Fabian, Bruce F. Kimler — 2002
• 17α-Methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in cultureGil Mor, Mariel Eliza, Joon Ho Song — 2001
• Catechol estrogens induce oxidative DNA damage and estradiol enhances cell proliferationYusuke Hiraku, Naruto Yamashita, Meiko Nishiguchi — 2001
• Use of biomarkers for breast cancer risk assessment and prevention.Carol J. Fabian, Bruce F. Kimler — 2007
• Biological rationale for endocrine therapy in breast cancer.William R. Miller — 2004
• Bioidentical Hormone Therapy: A Review of the EvidenceMichael D. Cirigliano — 2007
• Chemoprevention for High‐Risk Women: Tamoxifen and BeyondCarol J. Fabian, Bruce F. Kimler — 2001
• Use of risk determinants for different breast cancer prevention strategies.Mitch Dowsett — 2000
• Rapid estradiol/ERalpha signaling enhances aromatase enzymatic activity in breast cancer cells.Stefania Catalano, Ines Barone, Cinzia Giordano — 2009
• The prevention of breast cancerR S Prichard, A Hill, B. Dijkstra — 2003
• Chemoprevention of Breast CancerCarol J. Fabian, Bruce F. Kimler — 2002
• Reducing the risk of breast cancer.Rowan T. Chlebowski — 2000
• Antiaromatase agents: evolving role in adjuvant therapy.Stephen E. Jones — 2002
• Quimioprevención del cáncer de mamaFrank Castro, J. Rodríguez Alcalá — 2002

Related papers

• Structure-function studies of aromatase and its inhibitors: a progress report.Shiuan Chen, Fangming Zhang, Mark A. Sherman — 2003
• Seminars in Oncology: IntroductionAndrew J. Dannenberg, Raymond N. DuBois, Steven M. Dubinett — 2004
• Recent developments in steroidal and nonsteroidal aromatase inhibitors for the chemoprevention of estrogen-dependent breast cancer.Irshad Ahmad, Shagufta Shagufta — 2015
• Sequence-function correlation of aromatase and its interaction with reductaseYanyan Hong, Hongzhi Li, Yate-Ching Yuan — 2009
• Egonol gentiobioside and egonol gentiotrioside from Styrax perkinsiae promote the biosynthesis of estrogen by aromatase.Danfeng Lu, Lijuan Yang, Qilin Li — 2012
• Estimation of Breast Density from Human Mammograms using U-NetsSaikumar Yellari, Janaki P. Dharmarajan, Sanidhya Shilendra Karve — 2022
• Activity of aromatase in breast cancer tissue: Role of the cell substrateЛ. М. Берштейн, Alexey A. Larionov, A. Sh. Kyshtoobaeva — 1995
• Peroxidase activity in the rat breast tissue as a marker of estrogen action.Arnold Banerji, Somhrita Dutta — 1979
• Mammographic breast density as an intermediate phenotype for breast cancer.Norman F. Boyd, Johanna M. Rommens, Kelly Vogt — 2005